Kounis syndrome associated with remdesivir therapy in a COVID-19 patient
Clin Toxicol (Phila)
.
2023 Dec;61(12):1067-1069.
doi: 10.1080/15563650.2023.2295233.
Epub 2024 Jan 25.
Authors
Eirini Beneki
1
,
Kyriakos Dimitriadis
1
,
Alexandros Antonopoulos
1
,
Konstantina Aggeli
1
,
Konstantinos Tsioufis
1
Affiliation
1
First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.
PMID:
38174704
DOI:
10.1080/15563650.2023.2295233
No abstract available
MeSH terms
Adenosine Monophosphate / adverse effects
Alanine / analogs & derivatives*
COVID-19 Drug Treatment
COVID-19*
Humans
Kounis Syndrome*
Substances
remdesivir
Adenosine Monophosphate
Alanine